aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
InQ Biosciences provides advanced cell analysis systems and culture equipment, simulating human body conditions for disease research. Their InQ system integrates software-controlled environments with imaging and real-time data collection, enabling precise management of temperature, gas levels, media perfusion, and pressure for extended cell growth and analysis.
InQ Biosciences' innovative technology facilitates significant advancements in cell and tissue research, offering automated onboard microscopy with remote monitoring. Their systems have impacted the field by enhancing the accuracy and efficiency of cell analysis, contributing to breakthroughs in disease research and development.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Lab Equipment, Cell Analysis
Technology
Analytics, Biotech
Tags
Healthtech
Model Types
Hardware, Software
Revenue Type(s)
Recurring, Professional Services
Customer Type(s)
Enterprise, Research
Geographic Exposure
Global
When was InQ Biosciences founded?
InQ Biosciences was founded in 2007.
Where is InQ Biosciences’s headquarters located?
InQ Biosciences’s headquarters is located in Huntsville, AL, US.
When was InQ Biosciences’s last funding round?
InQ Biosciences’s most recent funding round was for $510k (USD) in March 2010.
How many employees does InQ Biosciences have?
InQ Biosciences has 11 employees as of Feb 5, 2024.
How much has InQ Biosciences raised to-date?
As of July 05, 2023, InQ Biosciences has raised a total of $510k (USD) since Mar 2, 2010.
Add Comparison
Total Raised to Date
$510k
USD
Last Update Mar 2, 2010
Last Deal Details
$510k
USD
Mar 2, 2010
Series Unknown
Total Employees Over Time
11
As of Feb 2024
InQ Biosciences Address
515 Sparkman Drive
Huntsville,
Alabama
35816
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts